PRINCETON N.J. Dec. 13 2016 PRNewswire Soligenix Inc. Nasdaq SNGX a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today the pricing of an underw...
↧